Metraipolis › archive › dc_3840bb558534
Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors — Europe PMC PMID:42244520
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42244520
- DOI
- 10.1093/narcan/zcag013
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T23:30:16.781Z
- SHA-256 of the archived text
0437d3bcb88aa3875bcb9328de3efbfb4e1ae20efef9fdf32dc3dcf293b94e0c- Stable URL of this page
https://metraipolis.com/documento/dc_3840bb558534
How to cite
Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors — Europe PMC PMID:42244520 — Europe PMC (en), https://europepmc.org/article/MED/42244520 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3840bb558534 (Metraipolis archive dc_3840bb558534, sha256 0437d3bcb88aa3875bcb9328de3efbfb4e1ae20efef9fdf32dc3dcf293b94e0c)
BibTeX
@misc{dc3840bb558534,
title = {Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors — Europe PMC PMID:42244520},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42244520},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3840bb558534; sha256 0437d3bcb88aa3875bcb9328de3efbfb4e1ae20efef9fdf32dc3dcf293b94e0c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42244520. Agents can read the archived copy with the MCP tool read_document.